WALKME LTD (WKME) Fundamental Analysis & Valuation

NASDAQ:WKME • IL0011765851

Current stock price

13.95 USD
0 (0%)
At close:
13.93 USD
-0.02 (-0.14%)
After Hours:

This WKME fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WKME Profitability Analysis

1.1 Basic Checks

  • WKME had positive earnings in the past year.
  • In the past year WKME had a positive cash flow from operations.
  • WKME had negative earnings in each of the past 5 years.
  • WKME had negative operating cash flow in 4 of the past 5 years.
WKME Yearly Net Income VS EBIT VS OCF VS FCFWKME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -9.47%, WKME perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
  • WKME's Return On Equity of -17.23% is in line compared to the rest of the industry. WKME outperforms 45.77% of its industry peers.
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
WKME Yearly ROA, ROE, ROICWKME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

  • The Gross Margin of WKME (85.25%) is better than 92.25% of its industry peers.
  • WKME's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WKME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
WKME Yearly Profit, Operating, Gross MarginsWKME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. WKME Health Analysis

2.1 Basic Checks

  • WKME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WKME has been increased compared to 1 year ago.
  • There is no outstanding debt for WKME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WKME Yearly Shares OutstandingWKME Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M
WKME Yearly Total Debt VS Total AssetsWKME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

  • WKME has an Altman-Z score of 2.93. This is not the best score and indicates that WKME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • WKME's Altman-Z score of 2.93 is in line compared to the rest of the industry. WKME outperforms 53.87% of its industry peers.
  • There is no outstanding debt for WKME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.93
ROIC/WACCN/A
WACC9.55%
WKME Yearly LT Debt VS Equity VS FCFWKME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 2.04 indicates that WKME has no problem at all paying its short term obligations.
  • WKME's Current ratio of 2.04 is fine compared to the rest of the industry. WKME outperforms 61.97% of its industry peers.
  • WKME has a Quick Ratio of 2.04. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
  • WKME has a better Quick ratio (2.04) than 61.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
WKME Yearly Current Assets VS Current LiabilitesWKME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. WKME Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 181.25% over the past year.
  • The Revenue has been growing slightly by 4.89% in the past year.
  • The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%

3.2 Future

  • WKME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.00% yearly.
  • Based on estimates for the next years, WKME will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WKME Yearly Revenue VS EstimatesWKME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
WKME Yearly EPS VS EstimatesWKME Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. WKME Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 53.65, WKME can be considered very expensive at the moment.
  • WKME's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.60. WKME is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 50.28 indicates a quite expensive valuation of WKME.
  • The rest of the industry has a similar Price/Forward Earnings ratio as WKME.
  • When comparing the Price/Forward Earnings ratio of WKME to the average of the S&P500 Index (22.84), we can say WKME is valued expensively.
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
WKME Price Earnings VS Forward Price EarningsWKME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, WKME is valued a bit cheaper than the industry average as 77.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.09
EV/EBITDA N/A
WKME Per share dataWKME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • WKME's earnings are expected to grow with 147.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y204.11%
EPS Next 3Y147.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WKME Dividend Analysis

5.1 Amount

  • WKME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

WKME Fundamentals: All Metrics, Ratios and Statistics

WALKME LTD

NASDAQ:WKME (9/11/2024, 8:00:44 PM)

After market: 13.93 -0.02 (-0.14%)

13.95

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-01
Earnings (Next)N/A
Inst Owners9.06%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.30B
Revenue(TTM)272.99M
Net Income(TTM)-45.19M
Analysts51.67
Price Target14.08 (0.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.64%
Min EPS beat(2)84.28%
Max EPS beat(2)183%
EPS beat(4)4
Avg EPS beat(4)217.58%
Min EPS beat(4)84.28%
Max EPS beat(4)482.59%
EPS beat(8)8
Avg EPS beat(8)132.3%
EPS beat(12)11
Avg EPS beat(12)93.01%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.76%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.38%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.05%
EPS NQ rev (3m)-10.24%
EPS NY rev (1m)0.16%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
P/S 4.76
P/FCF 28.09
P/OCF 27.79
P/B 4.95
P/tB 4.98
EV/EBITDA N/A
EPS(TTM)0.26
EY1.86%
EPS(NY)0.28
Fwd EY1.99%
FCF(TTM)0.5
FCFY3.56%
OCF(TTM)0.5
OCFY3.6%
SpS2.93
BVpS2.82
TBVpS2.8
PEG (NY)0.08
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.25%
FCFM 16.93%
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 8.18%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 2.93
F-Score6
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)43.23%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%
EBIT growth 1Y61.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.4%
EBIT Next 3Y100.46%
EBIT Next 5Y56.37%
FCF growth 1Y178.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y187.4%
OCF growth 3YN/A
OCF growth 5YN/A

WALKME LTD / WKME Fundamental Analysis FAQ

What is the fundamental rating for WKME stock?

ChartMill assigns a fundamental rating of 4 / 10 to WKME.


Can you provide the valuation status for WALKME LTD?

ChartMill assigns a valuation rating of 4 / 10 to WALKME LTD (WKME). This can be considered as Fairly Valued.


Can you provide the profitability details for WALKME LTD?

WALKME LTD (WKME) has a profitability rating of 2 / 10.


What is the valuation of WALKME LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for WALKME LTD (WKME) is 53.65 and the Price/Book (PB) ratio is 4.95.


Can you provide the expected EPS growth for WKME stock?

The Earnings per Share (EPS) of WALKME LTD (WKME) is expected to grow by 643.24% in the next year.